The 2025 Bitcoin Mining Review is here. Download your free copy.

Sunshine Biopharma, Inc.

SBFM
$1.23 (-1.6%) 05:39 PM 23/01/26

Market

Market Overview

Market Cap
Shares Outstanding
50-Day Moving Average
200-Day Moving Average
Average Volume (20 Days)
Beta (5Y)
  • Chart chart view
  • Table table view
  • Price
  • Market Cap MCap
  • Shares
Start Date
start date
to
End Date
start date

About

Company Overview

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.

Stock Exchange NASDAQ
IPO Date 2022-02-15
Number of Employees 52
Headquarters Pointe-Claire, QC, CA

News

Press Releases

FAQ

The next earnings report date for Sunshine Biopharma, Inc. (SBFM) is scheduled for May 13, 2026. Stay up to date with SBFM’s financial results and key announcements by visiting our Earnings Tracker or by subscribing to earnings alerts. Here we also provide SBFM earnings call summaries and transcripts.

The current stock price of Sunshine Biopharma, Inc. (SBFM) is $1.23 as of 05:39 PM 23/01/26. For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.